Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer

被引：4
|
作者：
Jacobson, Anne
机构：
来源：
ONCOLOGIST | 2022年 / 27卷
关键词：
D O I：
10.1093/oncolo/oyac015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer
    Jacobson, Anne
    ONCOLOGIST, 2022, 27 (SUPPL 1): : S7 - S8
  • [2] Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer
    Kinikoglu, Oguzcan
    Odabas, Hatice
    Altintas, Yunus Emre
    Yildiz, Anil
    Cakan, Burcin
    Akdag, Goncaguel
    Yildirim, Sedat
    Bal, Hamit
    Kaya, Tugba
    Tunbekici, Salih
    Isik, Deniz
    Basoglu, Tugba
    Yildirim, Mahmut Emre
    Turan, Nedim
    MEDICINA-LITHUANIA, 2024, 60 (06):
  • [3] Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
    Pauline Corbaux
    Audrey Lardy-Cleaud
    Marie Alexandre
    Maxime Fontanilles
    Christelle Lévy
    Alessandro Adriano Viansone
    Audrey Mailliez
    Marc Debled
    Anthony Goncalves
    Fanny Le Du
    Florence Lerebours
    Jean-Marc Ferrero
    Jean-Christophe Eymard
    Marie-Ange Mouret-Reynier
    Thierry Petit
    Jean-Sébastien Frenel
    Florence Dalenc
    Coralie Courtinard
    Marie Chaix
    Thomas Bachelot
    Breast Cancer Research and Treatment, 2022, 191 : 191 - 207
  • [4] Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
    Corbaux, Pauline
    Lardy-Cleaud, Audrey
    Alexandre, Marie
    Fontanilles, Maxime
    Levy, Christelle
    Viansone, Alessandro Adriano
    Mailliez, Audrey
    Debled, Marc
    Goncalves, Anthony
    Le Du, Fanny
    Lerebours, Florence
    Ferrero, Jean-Marc
    Eymard, Jean-Christophe
    Mouret-Reynier, Marie-Ange
    Petit, Thierry
    Frenel, Jean-Sebastien
    Dalenc, Florence
    Courtinard, Coralie
    Chaix, Marie
    Bachelot, Thomas
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (01) : 191 - 207
  • [5] Evaluating the Response of Palbociclib on Progression-Free Survival in Hormone Receptor-Positive Metastatic Breast Cancer
    Shikdar, Sufana
    Hall, Spencer
    Taylor, Brandon
    de los Angeles, Jennifer
    Tahirkheli, Mashal
    Zhao, Daniel
    Razaq, Wajeeha
    ONCOLOGY, 2022, 100 (06) : 337 - 343
  • [6] Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review
    Reinert, Tomas
    Barrios, Carlos H.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (11) : 693 - 709
  • [7] ELACESTRANT PROLONGS PROGRESSION-FREE SURVIVAL IN ADVANCED BREAST CANCER
    不详
    CANCER DISCOVERY, 2022, 12 (07) : 1609 - 1609
  • [8] Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer
    Kaklamani, Virginia G.
    Gradishar, William J.
    ONCOLOGIST, 2017, 22 (05): : 507 - 517
  • [9] Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer
    Wilkie, Jonathan
    Schickli, M. Alexandra
    Berger, Michael J.
    Lustberg, Maryam
    Reinbolt, Raquel
    Noonan, Anne
    Ramaswamy, Bhuvaneswari
    Sardesai, Sagar
    VanDeusen, Jeffrey
    Wesolowski, Robert
    Williams, Nicole
    Stover, Daniel G.
    Li, Junan
    Vargo, Craig A.
    CLINICAL BREAST CANCER, 2020, 20 (01) : 33 - 40
  • [10] Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer
    Yamashita, H.
    Nishio, M.
    Ando, Y.
    Zhang, Z.
    Hamaguchi, M.
    Mita, K.
    Kobayashi, S.
    Fujii, Y.
    Iwase, H.
    ENDOCRINE-RELATED CANCER, 2006, 13 (03) : 885 - 893
12345